Clearly, further studies are needed to disentangle the role of brain insulin responsiveness and inflammation in the development of obesity and associated diseases, as subclinical low-grade inflammation is well known to affect metabolic regulation. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.